25/05/2026Published by Fondazione Gianni Bonadonna at 25/05/2026Categories Events UncategorizedTucatinib plus trastuzumab in chemotherapy-refractory metastatic colorectal cancer
18/05/2026Published by Fondazione Gianni Bonadonna at 18/05/2026Categories Events UncategorizedPARP inhibitor rechallenge plus bevacizumab in ovarian cancer
11/05/2026Published by Fondazione Gianni Bonadonna at 11/05/2026Categories Events UncategorizedA new edition for the international fellowships in honor of Gianni Bonadonna
04/05/2026Published by Fondazione Gianni Bonadonna at 04/05/2026Categories Events UncategorizedFecal microbiota transplantation plus immunotherapy in non small cell lung cancer and melanoma
27/04/2026Published by Fondazione Gianni Bonadonna at 27/04/2026Categories Events UncategorizedThe use of intratumoral radioenhancer nanoparticle NBTXR3 in head and neck cancer
20/04/2026Published by Fondazione Gianni Bonadonna at 20/04/2026Categories Events UncategorizedZanidatamab in HER2- positive metastatic biliary tract cancer
13/04/2026Published by Fondazione Gianni Bonadonna at 13/04/2026Categories Events UncategorizedA comparison of mFOLFRINOX versus PAXG in pancreatic ductal adenocarcinoma
30/03/2026Published by Fondazione Gianni Bonadonna at 30/03/2026Categories Events UncategorizedPalbociclib added to anti-HER2 and endocrine therapies in advanced breast cancer. Results from the PATINA study
23/03/2026Published by Fondazione Gianni Bonadonna at 23/03/2026Categories Events UncategorizedNeoadjuvant ipilimumab plus nivolumab in melanoma